ConductScience.org, home

Trial · NCT07913412

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryLocal controlAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.Local control
PrimaryFunction: Visual acuity:At 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.Visual function assessed separately for each eye. Visual acuity: decimal scale,range 2,0 - 0,01: decimal acuity scale
PrimaryQuality of Life, ophthalmic cancer-specific quality of lifeAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.
Quality of Life, ophthalmic cancer-specific quality of life 1\) EORTC QLQ-OPT30 (ophthalmic cancer-specific quality of life): Scores range from 0-100; higher scores indicate greater visual impairment, ocular symptoms, and functional difficulties.
PrimaryProgression Free SurvivalAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.Progression Free Survival
PrimaryOverall SurvivalAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.Overall Survival
PrimaryFunction: Visual acuity:At 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.
Visual function assessed separately for each eye. Visual acuity: decimal scale,range 2,0 - 0,01: decimal acuity scale; furthermore, 1.Count-fingers, 2.hand-motion and 3.light-perception categories are recorded separately when acuity cannot be quantified: for each item: value yes / no
PrimaryFunction: Visual fieldAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.Visual field: Automated perimetry, Visual Field Index (VFI, %): 0 % - 100%,
PrimaryQuality of Life general quality of lifeAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.
EORTC QLQ-C30 (general quality of life): Scores range from 0-100; A) higher scores indicate better functioning/global quality of life B) symptom scores: indicate greater symptom burden on symptom scales.
PrimaryFunction: Retinal Nerve Fiber LayerAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.Optical coherence tomography (OCT): Peripapillary retinal nerve fiber layer (RNFL) thickness, measured in µm and classified in percentiles (regarding normal values)
PrimaryCorneaAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.corneal outcome: thickness measured in µm
PrimaryCorneaAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.
Corneal outcome modified Stocker's classification: category 0 No damage no injury category 1 corneal guttae without epithelial or stromal edema. category 2 corneal guttae with epithelial or stromal edema. category 3 corneal edema associated with scar formation. category 4 corneal opacification with neovascularization, modified Stocker's classification
PrimaryCorneal overall outcome classificationAt 3 months, every 6 months up to 24 months, and annually thereafter up to 60 -120 months.category 0 No corneal-ulcus category 1 Irregular punctate epithelial defects category 2 Non-healing epithelial defects / persistent epithelial defect (PED) category 3 Ulcer perforation

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07913412/registered